NEW YORK (GenomeWeb News) – Gentel Biosciences said today that it has signed a licensing agreement with diagnostic firm PriTest that expands its intellectual property portfolio in the area of nitrocellulose coatings for protein microarrays.
Under the terms of the exclusive agreement, Gentel has licensed US Patent No. 6,861,251, “Translucent solid matrix assay device for microarray analysis,” which covers arrays with a translucent nitrocellulose surface.
Gentel said in a statement that nitrocellulose surface chemistry offers “unparalleled sensitivity and dynamic range for protein microarray applications.”
The company did not disclose the financial terms of the licensing agreement.